Hospira Docetaxel Injection, 120 mg/12 mL, single vial

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

docetaxel, Quantity: 10 mg/mL

Disponible des:

Hospira Australia Pty Ltd

Designació comuna internacional (DCI):

Docetaxel

formulario farmacéutico:

Injection

Composición:

Excipient Ingredients: citric acid; ethanol absolute; polysorbate 80; polyethylene glycol monomethyl ether

Vía de administración:

Intravenous Infusion

Unidades en paquete:

1 x 15 mL vial

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

Breast cancer, Non-small cell lung cancer, Stomach cancer, Head and neck cancer, Ovarian cancer, Oesophageal cancer, Uterine cancer, Prostate cancer

Resumen del producto:

Visual Identification: A clear, colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert

Estat d'Autorització:

Licence status A

Data d'autorització:

2013-10-25